IDEAS home Printed from https://ideas.repec.org/p/irh/wpaper/dt16.html
   My bibliography  Save this paper

Drug price setting and regulation in France

Author

Listed:
  • Nathalie Grandfils

    () (IRDES Institute for research and information in health economics)

Abstract

In France, drug prices have historically been regulated but approaches to setting and regulating prices have been evolving in recent years. In 2003, the prices of new outpatient drugs, which had hitherto been entirely regulated, were semi-liberalised, with drug companies setting prices in line with those in neighbouring countries; and in parallel with this in 2004, the prices of expensive drugs and/or drugs qualifying for reassignment must now also be set in line with European prices. In addition to this, price/volume regulation has recently been introduced. This document describes the price setting rules applicable to each drug category and discusses different measures for regulating drug price, particu-larly the conventional policies implemented under successive framework agreements. The regulatory path for medicines and the different actors involved are presented in an Appendix.

Suggested Citation

  • Nathalie Grandfils, 2008. "Drug price setting and regulation in France," Working Papers DT16, IRDES institut for research and information in health economics, revised Sep 2008.
  • Handle: RePEc:irh:wpaper:dt16
    as

    Download full text from publisher

    File URL: http://www.irdes.fr/EspaceAnglais/Publications/WorkingPapers/DT16DrugPriceSettingRegulationFrance.pdf
    File Function: First version, 2008
    Download Restriction: no

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Corinne Blanquart & Saskia Seidel & Ina Frenzel, 2018. "A conceptual framework to identify key drivers for logistics and transport demand - testing the scheme for goods movement in the pharmaceutical supply chain in France and Germany
      [Un cadre conceptu
      ," Post-Print hal-01919122, HAL.

    More about this item

    Keywords

    Drugs; Regulation; Public Health;

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:irh:wpaper:dt16. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jacques Harrouin). General contact details of provider: http://edirc.repec.org/data/credefr.html .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.